specialty clinics
Scope
Date
~
-
Bio & Pharma
Celltrion gets FDA nod for Keytruda copy's phase 3 clinical trials
Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...
Aug 12, 2024 (Gmt+09:00)
-
Chemical Industry
Hyosung to sell its specialty gas unit for $943 mn to Korean PEs
South Korea’s Hyosung Group is poised to sell a 100% stake in its specialty and industrial gas unit to a consortium led by IMM Private Equity ...
Jul 12, 2024 (Gmt+09:00)
-
Chemical Industry
Lotte Chemical develops anti-thermal runaway material
Lotte Chemical Corp., South Korea’s second-largest petrochemicals company seeking to ramp up value-added advanced materials production, has de...
Jun 20, 2024 (Gmt+09:00)
-
Private equity
Affirma Capital seeks to sell entire stake in both SeAH FS, S&G Holdings
Affirma Capital, a Singapore-based buyout private equity firm, is seeking to sell its entire stake in both South Korean steel tube maker SeAH FS and...
Jun 20, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman
WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...
May 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Global quest to find modern elixirs enters new chapter
NEW YORK/ BOSTON – Longevity has long been the dream of humankind. China’s first emperor Qin Shi Huang was obsessed with finding magic e...
Mar 26, 2024 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma aims to boost Alyglo sales sixfold in the US
CHEONGJU, North Chungcheong Province -- South Korea’s major pharmaceutical company GC Biopharma Corp. aims to raise the sales of Alyglo, its i...
Feb 28, 2024 (Gmt+09:00)
-
Chemical Industry
Lotte Chemical completes HEC plant in Yeosu
South Korea’s Lotte Chemical Corp. announced on Monday its commencement of commercial production at the plant of Hydroxy Ethyl Cellulose (prod...
Feb 19, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom to enter Australian pet clinics market in H1
South Korea’s SK Telecom Co. announced on Tuesday that it has signed a commercial contract with ATX Medical Solutions, Australia's largest m...
Feb 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Bio & Pharma
CGBio gets FDA approval for Novosis Putty
South Korea's bio-regenerative medical firm CGBio announced on Tuesday that its Novosis Putty has been designated as a breakthrough device by the US...
Jan 02, 2024 (Gmt+09:00)
-
Upcoming IPOs
Peter Thiel-backed D&D Pharmatech gets preliminary nod for IPO
South Korean clinical-stage biotech D&D Pharmatech Inc. has won approval from the Korea Exchange’s preliminary review for listing on the j...
Dec 22, 2023 (Gmt+09:00)
-
Chemical Industry
Samyang buys specialty chemical maker Verdant for $257 mn
Samyang Specialty Solutions LLC, a leading chemical and food products maker in South Korea, has entered into an agreement to wholly acquire Texas-ba...
Dec 18, 2023 (Gmt+09:00)
-
Electronics
LG Elec launches new medical monitor
LG Electronics Inc. unveiled a new medical monitor on Wednesday. This monitor boasts high brightness suitable for both clinical and diagnostic purpo...
Dec 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N reveals differentiated clinical results for K-CAB
South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Korean chipmakers
SK Hynix pins high hopes on specialty DRAM for AI use: CEO
In the semiconductor industry, it’s been quite a while since memory chips became a commodity, meaning so low an entry barrier that any chipmak...
Oct 10, 2023 (Gmt+09:00)
-
Petrochemicals
Lotte Chemical sells JV stakes in China, eyes other profitable markets
South Korea’s Lotte Chemical Corp. has sold its entire stakes in joint ventures with Chinese partners as the Korean company faces a supply glu...
Oct 09, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax's US subsidiary listed on Nasdaq
South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong to develop eye drops for diabetic retinopathy
South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...
Sep 15, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell Bio's treatment shows promise for advanced liver cancer
South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Wellmarker Bio signs worth of $528 mn tech transfer deal
Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...
Sep 12, 2023 (Gmt+09:00)
-
KOREA Investment Week
Celltrion builds clinical data bank for new biosimilars
The use of data and computing is a new paradigm in the biopharmaceutical industry, reducing the new drug development time and cost, Celltrion Inc. C...
Sep 12, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Yungjin Pharm's new drug candidate gets Fast Track from FDA
South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...
Sep 06, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to participate in S.Korea’s new drug project
South Korea's JW Pharmaceutical announced on Monday that its experimental hair loss drug, JW0061, has been selected for a two-year funding program b...
Aug 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)